Use of bisphosphonates in advanced prostate cancer: Current status

Use of bisphosphonates in advanced prostate cancer: Current status

Bibliographic Details
Main Author:	Wolfgang Lilleby
Format:	Article
Language:	English
Published:	Wolters Kluwer Medknow Publications 2007-01-01
Series:	Indian Journal of Urology
Online Access:	http://www.indianjurol.com/article.asp?issn=0970-1591;year=2007;volume=23;issue=1;spage=54;epage=54;aulast=Lilleby

Similar Items

Use of bisphosphonates in prostate cancer: Current status
by: Rishi Nayyar, et al.
Published: (2007-01-01)

Bisphosphonates Treatment in Metastatic Prostate Cancer
by: F. Berardinelli, et al.
Published: (2005-05-01)

Ablative Radiotherapy in Prostate Cancer: Stereotactic Body Radiotherapy and High Dose Rate Brachytherapy
by: Ting Martin Ma, et al.
Published: (2020-12-01)

Radiotherapy and inhibition of the EGF family as treatment strategies for prostate cancer: combining theragnostics with theragates
by: Wolfgang Lilleby, et al.
Published: (2011-06-01)

The Current Status of Prostate Cancer*
by: Mukund S. Joshi
Published: (2018-10-01)

Lutetium-177 Labelled PSMA Targeted Therapy in Advanced Prostate Cancer: Current Status and Future Perspectives
by: Konstantin Egon Seitzer, et al.
Published: (2021-07-01)

Metastatic-directed therapy using PSMA-PET/CT at PSA relapse
by: Oscar Lilleby, et al.
Published: (2019-11-01)

Focal therapy for prostate cancer: The current status
by: Susan Marshall, et al.
Published: (2015-06-01)

Current status of active surveillance in prostate cancer
by: Mun Su Chung, et al.
Published: (2016-01-01)

BISPHOSPHONATES IN PROPHYLAXIS OF SKELETAL-RELATED ADVERSE EVENTS IN PATIENTS WITH CASTRATION-REFRACTORY PROSTATE CANCER
by: E. Yu. Safronova, et al.
Published: (2016-06-01)

BISPHOSPHONATE INDUCED OSTEONECROSIS OF THE JAWS AND CURRENT THERAPIES
by: Damla Torul, et al.
Published: (2017-08-01)

Bisphosphonates and tissue restoration: Current and future opportunities
by: Russell, G
Published: (2007)

Bones, breasts, and bisphosphonates: rationale for the use of zoledronic acid in advanced and early breast cancer
by: Allan Lipton
Published: (2011-03-01)

On the Road to Accurate Protein Biomarkers in Prostate Cancer Diagnosis and Prognosis: Current Status and Future Advances
by: Yiwu Yan, et al.
Published: (2021-12-01)

The Quandary of DNA-Based Treatment Assessment in De Novo Metastatic Prostate Cancer in the Era of Precision Oncology
by: Sigve Nakken, et al.
Published: (2021-04-01)

Bisphosphonates and colon cancer: Reply
by: Pazianas, M, et al.
Published: (2013)

Bisphosphonates and colon cancer: reply.
by: Pazianas, M, et al.
Published: (2013)

Hypocalcaemia in patients with prostate cancer treated with a bisphosphonate or denosumab: prevention supports treatment completion
by: Jean-Jacques Body, et al.
Published: (2018-09-01)

The current status of prostate cancer treatment and PSMA theranostics
by: Motohide Uemura, et al.
Published: (2023-07-01)

Focal therapy for localized prostate cancer – Current status
by: Shrikanth Atluri, et al.
Published: (2022-01-01)

Machine Learning in Prostate MRI for Prostate Cancer: Current Status and Future Opportunities
by: Huanye Li, et al.
Published: (2022-01-01)

Machine learning in prostate MRI for prostate cancer: current status and future opportunities
by: Li, Huanye, et al.
Published: (2022)

Bisphosphonate drug holidays: Can we recommend currently?
by: Vishal R Tandon, et al.
Published: (2014-01-01)

Bisphosphonates
by: Bishop, N, et al.
Published: (2013)

Bisphosphonates
by: Fırat Öztürk
Published: (2009-04-01)

Circulating Tumor Cell Persistence Associates with Long-Term Clinical Outcome to a Therapeutic Cancer Vaccine in Prostate Cancer
by: Ingrid Jenny Guldvik, et al.
Published: (2021-06-01)

Bispecific Antibodies in Prostate Cancer Therapy: Current Status and Perspectives
by: Jonas S. Heitmann, et al.
Published: (2021-02-01)

Current status of liquid biopsies for the detection and management of prostate cancer
by: Lu YT, et al.
Published: (2019-06-01)

Immunotherapy in Advanced Prostate Cancer: Current Knowledge and Future Directions
by: Fernando López-Campos, et al.
Published: (2022-02-01)

Current advances of liquid biopsies in prostate cancer: Molecular biomarkers
by: Murad Alahdal, et al.
Published: (2023-09-01)

Current advances of targeting epigenetic modifications in neuroendocrine prostate cancer
by: Wen-Chi Cheng, et al.
Published: (2021-01-01)

Surface bisphosphonation of polyetheretherketone to manipulate immune response for advanced osseointegration
by: Weifang Zhang, et al.
Published: (2023-08-01)

Impact of Bisphosphonate Therapy on Oral Health in Patients with Breast and Prostate Cancer and Bone Metastases: A Comprehensive Study
by: Jacek Calik, et al.
Published: (2024-03-01)

Safety of bisphosphonates.
by: Pazianas, M, et al.
Published: (2011)

Bisphosphonates: An update
by: Nalliappan Ganapathy, et al.
Published: (2012-01-01)

Bisphosphonates 2006
by: Russell, R
Published: (2006)

Current Status and Application of Metformin for Prostate Cancer: A Comprehensive Review
by: Hyun Kyu Ahn, et al.
Published: (2020-11-01)

Current Status of Biparametric MRI in Prostate Cancer Diagnosis: Literature Analysis
by: Mason James Belue, et al.
Published: (2022-05-01)

Administration of bisphosphonate for hypercalcemia associated with oral cancer
by: Yoshida Hiroshi, et al.
Published: (2006-04-01)

Hormonal status in patients with advanced prostatic cancer on the therapy with androgen blockade
by: Vojinov Saša, et al.
Published: (2011-01-01)